79 related articles for article (PubMed ID: 197173)
1. Mechanisms of disease and immunity in cholera: a review.
Holmgren J; Svennerholm AM
J Infect Dis; 1977 Aug; 136 Suppl():S105-12. PubMed ID: 197173
[TBL] [Abstract][Full Text] [Related]
2. Nature of Intestinal Secretions in Cholera.
West J Med Surg; 1847 Dec; 8(6):515. PubMed ID: 38210211
[No Abstract] [Full Text] [Related]
3. Cholera transmission: the host, pathogen and bacteriophage dynamic.
Nelson EJ; Harris JB; Morris JG; Calderwood SB; Camilli A
Nat Rev Microbiol; 2009 Oct; 7(10):693-702. PubMed ID: 19756008
[TBL] [Abstract][Full Text] [Related]
4. The nature and action of cholera toxin.
Van Heyningen WE; Van Heyningen S; King CA
Ciba Found Symp; 1976; (42):73-88. PubMed ID: 791600
[TBL] [Abstract][Full Text] [Related]
5. Oral immunization with
Shrivastava S; Agnememel AB; Ndungo E; Islam D; Liang Y; Frenck RW; Pasetti MF
mSphere; 2024 Jan; 9(1):e0041923. PubMed ID: 38132716
[No Abstract] [Full Text] [Related]
6. Cholera, the Current Status of Cholera Vaccines and Recommendations for Travellers.
Gabutti G; Rossanese A; Tomasi A; Giuffrida S; Nicosia V; Barriga J; Florescu C; Sandri F; Stefanati A
Vaccines (Basel); 2020 Oct; 8(4):. PubMed ID: 33066373
[TBL] [Abstract][Full Text] [Related]
7. The heptameric structure of the flagellar regulatory protein FlrC is indispensable for ATPase activity and disassembled by cyclic-di-GMP.
Chakraborty S; Biswas M; Dey S; Agarwal S; Chakrabortty T; Ghosh B; Dasgupta J
J Biol Chem; 2020 Dec; 295(50):16960-16974. PubMed ID: 32998953
[TBL] [Abstract][Full Text] [Related]
8.
Weil AA; Becker RL; Harris JB
mSphere; 2019 Nov; 4(6):. PubMed ID: 31776240
[No Abstract] [Full Text] [Related]
9. IgM specific to lipopolysaccharide of Vibrio cholerae is a surrogate antibody isotype responsible for serum vibriocidal activity.
Yang JS; An SJ; Jang MS; Song M; Han SH
PLoS One; 2019; 14(3):e0213507. PubMed ID: 30845262
[TBL] [Abstract][Full Text] [Related]
10. Cholera: Immunity and Prospects in Vaccine Development.
Harris JB
J Infect Dis; 2018 Oct; 218(suppl_3):S141-S146. PubMed ID: 30184117
[TBL] [Abstract][Full Text] [Related]
11. Fucosylated Molecules Competitively Interfere with Cholera Toxin Binding to Host Cells.
Wands AM; Cervin J; Huang H; Zhang Y; Youn G; Brautigam CA; Matson Dzebo M; Björklund P; Wallenius V; Bright DK; Bennett CS; Wittung-Stafshede P; Sampson NS; Yrlid U; Kohler JJ
ACS Infect Dis; 2018 May; 4(5):758-770. PubMed ID: 29411974
[TBL] [Abstract][Full Text] [Related]
12. Spermine inhibits
Sobe RC; Bond WG; Wotanis CK; Zayner JP; Burriss MA; Fernandez N; Bruger EL; Waters CM; Neufeld HS; Karatan E
J Biol Chem; 2017 Oct; 292(41):17025-17036. PubMed ID: 28827313
[TBL] [Abstract][Full Text] [Related]
13. Vibrio cholerae LeuO Links the ToxR Regulon to Expression of Lipid A Remodeling Genes.
Bina XR; Howard MF; Ante VM; Bina JE
Infect Immun; 2016 Nov; 84(11):3161-3171. PubMed ID: 27550934
[TBL] [Abstract][Full Text] [Related]
14. Conjugated Linoleic Acid Reduces Cholera Toxin Production In Vitro and In Vivo by Inhibiting Vibrio cholerae ToxT Activity.
Withey JH; Nag D; Plecha SC; Sinha R; Koley H
Antimicrob Agents Chemother; 2015 Dec; 59(12):7471-6. PubMed ID: 26392502
[TBL] [Abstract][Full Text] [Related]
15. A small unstructured region in Vibrio cholerae ToxT mediates the response to positive and negative effectors and ToxT proteolysis.
Thomson JJ; Plecha SC; Withey JH
J Bacteriol; 2015 Feb; 197(3):654-68. PubMed ID: 25422303
[TBL] [Abstract][Full Text] [Related]
16. RNA thermometer controls temperature-dependent virulence factor expression in Vibrio cholerae.
Weber GG; Kortmann J; Narberhaus F; Klose KE
Proc Natl Acad Sci U S A; 2014 Sep; 111(39):14241-6. PubMed ID: 25228776
[TBL] [Abstract][Full Text] [Related]
17. The utility of human challenge studies in vaccine development: lessons learned from cholera.
Shirley DA; McArthur MA
Vaccine (Auckl); 2011 Oct; 2011(1):3-13. PubMed ID: 24482781
[TBL] [Abstract][Full Text] [Related]
18. Frequency of reexposure to Vibrio cholerae O1 evaluated by subsequent vibriocidal titer rise after an episode of severe cholera in a highly endemic area in Bangladesh.
Weil AA; Chowdhury F; Khan AI; Leung DT; Uddin T; Begum YA; Saha NC; Charles RC; Larocque RC; Harris JB; Ryan ET; Qadri F; Calderwood SB
Am J Trop Med Hyg; 2012 Nov; 87(5):921-6. PubMed ID: 22964723
[TBL] [Abstract][Full Text] [Related]
19. New-generation vaccines against cholera.
Clemens J; Shin S; Sur D; Nair GB; Holmgren J
Nat Rev Gastroenterol Hepatol; 2011 Nov; 8(12):701-10. PubMed ID: 22064524
[TBL] [Abstract][Full Text] [Related]
20. N-terminal residues of the Vibrio cholerae virulence regulatory protein ToxT involved in dimerization and modulation by fatty acids.
Childers BM; Cao X; Weber GG; Demeler B; Hart PJ; Klose KE
J Biol Chem; 2011 Aug; 286(32):28644-55. PubMed ID: 21673111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
